Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/7590Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Post, A. | en |
| dc.contributor.author | Rucker, M. | en |
| dc.contributor.author | Ohl, F. | en |
| dc.contributor.author | Uhr, M. | en |
| dc.contributor.author | Holsboer, F. | en |
| dc.contributor.author | Almeida, O. F. X. | en |
| dc.contributor.author | Michaelidis, T. M. | en |
| dc.date.accessioned | 2015-11-24T16:32:48Z | - |
| dc.date.available | 2015-11-24T16:32:48Z | - |
| dc.identifier.issn | 0893-133X | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/7590 | - |
| dc.rights | Default Licence | - |
| dc.subject | haloperidol | en |
| dc.subject | nf-kappa b/i kappa-b | en |
| dc.subject | p53 | en |
| dc.subject | apoptosis | en |
| dc.subject | bax | en |
| dc.subject | tardive dyskinesia | en |
| dc.subject | nf-kappa-b | en |
| dc.subject | programmed cell-death | en |
| dc.subject | neuroleptic drug haloperidol | en |
| dc.subject | vacuous chewing movements | en |
| dc.subject | tumor-suppressor p53 | en |
| dc.subject | elevated plus-maze | en |
| dc.subject | tardive-dyskinesia | en |
| dc.subject | oxidative stress | en |
| dc.subject | nervo | en |
| dc.title | Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidol-associated neurotoxicity | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | <Go to ISI>://000173976300013 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιών | el |
| heal.publicationDate | 2002 | - |
| heal.abstract | The undesired side-effects of haloperidol treatment include a number of extrapyramidal side-effects which have been proposed to result from drug-induced damage to the basal ganglia. The drug also causes irregular movements and locomotor patterns in experimental animals. Here we show that haloperidol treatment in rats is associated with increases in the expression of 1753 and the ratio of pro-apoptotic (Bax) to anti-apoptotic (Bcl-2/Bcl-x(1)) proteins in the hippocampus and caudate putamen (CPu). In addition, haloperidol induces the DNA binding activity of the redox-sensitive nuclear factor-kappa B (NF-kappaB) and concomitantly upregulates the levels of the phosphorylated form of IkappaBalpha protein in vivo. Similar responses are observed when a mouse hippocampal cell line (HT-22) is treated with haloperidol and/or vitamin E. Interestingly, all of these biochemical effects of haloperidol arc significantly attenuated when animals or cultured cells are pretreated with a-tocopherol (vitamin E). Consistent with this, vitamin E is demonstrated to substantially reduce the haloperidol-induced impairment of locomotor activity in rats. Collectively, the data indicate the usefulness of vitamin E as an adjunct to haloperidol treatment and provide initial clues about the underlying molecular mechanisms involved in these effects. (C) 2002 American College of Neuropsychopharmacology. Published by Elsevier Science Inc. | en |
| heal.journalName | Neuropsychopharmacology | en |
| heal.journalType | peer reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
